Skip to main content
Anthem Biosciences Limited logo

Anthem Biosciences Limited — Investor Relations & Filings

Ticker · ANTHEM ISIN · INE0CZ201020 LEI · 335800FNA941U9NMD221 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 84 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS ANTHEM

About Anthem Biosciences Limited

https://anthembio.com/

Anthem Biosciences Limited is a comprehensive Contract Research and Manufacturing Services (CRAMS) organization providing integrated solutions across the drug discovery and development lifecycle. The company offers services including medicinal chemistry, process research, analytical validation, and large-scale commercial manufacturing. Its technical expertise spans synthetic organic chemistry, fermentation technology, molecular biology, and cell biology, enabling the production of both small molecules and biologics. Anthem serves global clients in the pharmaceutical, biopharmaceutical, and specialty chemical sectors. The organization features state-of-the-art research facilities and cGMP-compliant manufacturing units, facilitating a seamless transition from initial concept to market-ready products. Its commitment to intellectual property protection and rigorous quality management systems underpins its collaborative partnerships.

Recent filings

Filing Released Lang Actions
Investors/Analyst Call Intimation to be schedule from June 02 2026 till June 05, 2026.
Regulatory Filings Classification · 85% confidence The document is an official intimation letter to stock exchanges (BSE & NSE) pursuant to SEBI Listing Regulations, disclosing the schedule of analyst/institutional investor meetings. It does not contain financial statements or presentation materials, nor is it a proxy, dividend notice, or management change. It is a routine regulatory disclosure under listing obligations. This fits best into the general Regulatory Filings (RNS) category.
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a stock exchange filing under SEBI LODR Regulation 30 to disclose the schedule of analyst/institutional investor meetings. It contains no financial data or presentation materials, only an intimation of event dates and venues. This is a generic regulatory announcement rather than an investor presentation, earnings release, or financial report. It best fits the fallback category for miscellaneous regulatory disclosures (Regulatory Filings).
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is the full text of an earnings conference call including management’s opening remarks, financial metrics, and Q&A. It is clearly a transcript of a company call (not just an announcement or summary). This matches the definition of a Call Transcript (CT).
2026-05-22 English
Earnings Call transcript for Earnings Call held on May 20, 2026, for the Audited Standalone and Consolidated financial results for the quarter and year ended March 31, 2026.
Call Transcript Classification · 98% confidence The document contains the full text of the Q4 & FY26 earnings conference call, including opening remarks by the CEO/CFO, moderated Q&A, page numbering, and call transcript formatting. It is not merely an earnings summary or announcement, but the complete conference call transcript. This matches the definition of a Call Transcript (CT).
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 87% confidence The document is a short notice to stock exchanges under SEBI regulations informing that the audio recording of the earnings call for the quarter and year ended March 31, 2026 is available on the company’s website. It does not contain the earnings results or transcript itself, but merely announces the publication of the audio recording. Per the “Menu vs Meal” rule, this is a report publication announcement, not the report or transcript itself.
2026-05-20 English
Audio recording of the Investor(s)/ Analyst(s) Call held on May 20, 2026, at 11:00 AM.
Regulatory Filings Classification · 85% confidence The document is a short notice to stock exchanges under SEBI LODR regulations informing the availability of an audio recording of the company’s earnings call. It does not contain financial results, actual financial statements, or a transcript. It simply announces that the audio file has been made available on the company website. This fits the definition of a general regulatory announcement that doesn’t neatly fit into other specific categories, so it should be classified as Regulatory Filings (RNS).
2026-05-20 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.